Dr Greg Fitzgibbon joins Metabolomic Diagnostics as Clinical Laboratory Director
Cork, Ireland, May 2022 – Metabolomic Diagnostics is delighted to welcome Dr Greg Fitzgibbon to the team as Clinical Laboratory…
May Is Preeclampsia Awareness Month
Metabolomic Diagnostics Is Working To Raise Preeclampsia Awareness Cork, Ireland, May 2022 –Metabolomics Diagnostics working to raise preeclampsia awareness. Metabolomics…
Metabolomics Diagnostics Announces Partnership With Preeclampsia Foundation
Cork, Ireland, May 2022 – Irish diagnostics company Metabolomics Diagnostics announces its corporate partnership with the Preeclampsia Foundation. The Preeclampsia…
Metabolomics Diagnostics Announces Partnership with US company Renegade.bio to Launch Preeclampsia Test in USA Market
Metabolomics Diagnostics Announces Partnership with US company Renegade.bio to Launch Preeclampsia Test in USA Market Cork Ireland and San Francisco…
Metabolomic Diagnostics appoints Dr. Ana Panigassi as Head of Clinical Affairs
Metabolomic Diagnostics, the Ireland based, deep tech medical diagnostics company, today announced the appointment of Dr. Ana Panigassi to the…
‘Plotting PPV and NPV Criterions in the ROC space – adding utility to biomarker analysis’ -MSACL
Metabolomic Diagnostics Robin Tuytten and Gregoire Thomas (SQU4RE- Metabolomic Diagnostics Partner) recently presented a webinar for the The Association for…